Literature DB >> 22565405

Influence of a multidisciplinary cancer board on treatment decisions.

Kenji Nemoto1, Misako Murakami, Mayumi Ichikawa, Ibuki Ohta, Takuma Nomiya, Mayumi Yamakawa, Yuriko Itho, Tadahisa Fukui, Takashi Yoshioka.   

Abstract

BACKGROUND: To clarify how a multidisciplinary cancer board (CB) influences treatment decisions.
METHODS: From March 2010 to June 2011, a total of 475 cases were discussed at our CB and the minutes of the board were reviewed for this study.
RESULTS: Of the 475 patients, minor changes in treatment methods were made in 42 patients (9 %) and major changes were made in 28 patients (6 %). Further diagnostic procedures, further publication surveys and reconfirmation of patient's wishes were recommended in 80 patients (17 %). In the 392 patients for whom treatment was recommended, the CB's recommendation was realized in 349 patients (89 %) and was not realized in 20 (5 %) patients.
CONCLUSIONS: It is obvious that a CB has a great influence on cancer treatment decisions, but the effectiveness of the CB in our hospital should be verified in the future by analyzing treatment outcomes.

Entities:  

Mesh:

Year:  2012        PMID: 22565405     DOI: 10.1007/s10147-012-0420-x

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  8 in total

1.  A prospective study of the clinical impact of a multidisciplinary head and neck tumor board.

Authors:  Stephen A Wheless; Kibwei A McKinney; Adam M Zanation
Journal:  Otolaryngol Head Neck Surg       Date:  2010-11       Impact factor: 3.497

2.  Evaluation of the tumor board as a Continuing Medical Education (CME) activity: is it useful?

Authors:  Maryclare Sarff; Wendy Rogers; Charles Blanke; John T Vetto
Journal:  J Cancer Educ       Date:  2008 Jan-Mar       Impact factor: 2.037

3.  Impact of a weekly multidisciplinary tumor board conference on the management of women with gynecologic malignancies.

Authors:  Heather O Greer; Peter J Frederick; Nicole M Falls; Emily B Tapley; Karen L Samples; Kristopher J Kimball; James E Kendrick; Michael G Conner; Lea Novak; J Michael Straughn
Journal:  Int J Gynecol Cancer       Date:  2010-11       Impact factor: 3.437

Review 4.  Multidisciplinary teams in cancer care: are they effective in the UK?

Authors:  Anne Fleissig; Valerie Jenkins; Susan Catt; Lesley Fallowfield
Journal:  Lancet Oncol       Date:  2006-11       Impact factor: 41.316

5.  Tumor board: more than treatment planning--a 1-year prospective survey.

Authors:  Troy A Gatcliffe; Robert L Coleman
Journal:  J Cancer Educ       Date:  2008       Impact factor: 2.037

6.  A multidisciplinary approach to the management of urologic malignancies: does it influence diagnostic and treatment decisions?

Authors:  Raj Kurpad; William Kim; W Kim Rathmell; Paul Godley; Young Whang; Julia Fielding; LuAnn Smith; Ava Pettiford; Heather Schultz; Matthew Nielsen; Eric M Wallen; Raj S Pruthi
Journal:  Urol Oncol       Date:  2009-07-03       Impact factor: 3.498

7.  Management of ovarian cancer: referral to a multidisciplinary team matters.

Authors:  E J Junor; D J Hole; C R Gillis
Journal:  Br J Cancer       Date:  1994-08       Impact factor: 7.640

8.  An evaluation of the impact of a multidisciplinary team, in a single centre, on treatment and survival in patients with inoperable non-small-cell lung cancer.

Authors:  L M Forrest; D C McMillan; C S McArdle; D J Dunlop
Journal:  Br J Cancer       Date:  2005-10-31       Impact factor: 7.640

  8 in total
  4 in total

1.  The Role of Cancer Boards in the Treatment Decisions Regarding Chemotherapy.

Authors:  Sho Nakamura; Tadahisa Fukui; Yuriko Ito Sasahara; Shuhei Suzuki; Hiroyuki Takeda; Misako Miwa; Mayumi Ichikawa; Kenji Nemoto; Mayumi Yamakawa; Takashi Yoshioka
Journal:  Intern Med       Date:  2016-11-01       Impact factor: 1.271

2.  Implementation rate and effects of multidisciplinary team meetings on decision making about radiotherapy: an observational study at a single Japanese institution.

Authors:  Mayumi Ichikawa; Ken Uematsu; Natsuko Yano; Masayoshi Yamada; Takashi Ono; Shohei Kawashiro; Hiroko Akamatsu; Yasuhito Hagiwara; Hiraku Sato; Kenji Nemoto
Journal:  BMC Med Inform Decis Mak       Date:  2022-04-27       Impact factor: 3.298

3.  Clinician perspectives on clinical decision support systems in lung cancer: Implications for shared decision-making.

Authors:  Anshu Ankolekar; Britt van der Heijden; Andre Dekker; Cheryl Roumen; Dirk De Ruysscher; Bart Reymen; Adriana Berlanga; Cary Oberije; Rianne Fijten
Journal:  Health Expect       Date:  2022-05-10       Impact factor: 3.318

4.  Status of radiotherapy in a multidisciplinary cancer board.

Authors:  Mayumi Ichikawa; Kenji Nemoto; Misako Miwa; Ibuki Ohta; Takuma Nomiya; Mayumi Yamakawa; Yuriko Itho; Tadahisa Fukui; Takashi Yoshioka
Journal:  J Radiat Res       Date:  2013-08-26       Impact factor: 2.724

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.